梭菌纲
医学
暴发型
粪便细菌疗法
背景(考古学)
重症监护医学
流行病学
传染病(医学专业)
艰难梭菌
感染控制
疾病
医疗保健
内科学
抗生素
微生物学
经济
古生物学
生物
经济增长
作者
Zahir Kanjee,Jessica R. Allegretti,Carolyn D. Alonso,Risa B. Burns
摘要
The Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and the American College of Gastroenterology recently released updated guidelines on management of patients with Clostridioides difficile infection. Although these 2 guidelines generally agree, there are a few important differences in their advice to clinicians. In these rounds, 2 experts, an infectious diseases specialist and a gastroenterologist, discuss antibiotic treatment options for nonsevere disease, the role of fecal microbiota transplantation for fulminant disease, and the use of bezlotoxumab to prevent recurrence in the context of Ms. C, a 48-year-old woman with fulminant C difficile infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI